Publication search

Antitumor and immunosuppressive activities of lankacidin-group antibiotics: structure-activity relationships.

Published in Cancer chemotherapy reports

The antitumor and immunosuppressive activities of the lankacidin-group antibiotics were studied in mice. Seventeen of 29 newly prepared lankacidin-group antibiotics, including 14-derivatives of lankacidin C, lankacidinol, isolankacidinol, and lankacidinol 14-acetate, possessed considerable antitumor activity against ascites 6C3HED/OG lymphosarcoma....

L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with th...

Published in Cancer chemotherapy reports

L-[alphaS,5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501), an antibiotic elaborated by Streptomyces sviceus, has been shown to be a powerful inhibitor of many mammalian and bacterial reactions involving the transfer of nitrogen from the gamma-carboxamide of L-glutamine. Thus, the utilization of L-glutamine for the synthesis...

Letter: Possible inhibitory effect of androgens on bone marrow suppression by cytotoxic agents--a dose-dependent phenome...

Published in Cancer chemotherapy reports

Drug-tumor sensitivity matching procedure using diffusion chambers in vivo.

Published in Cancer chemotherapy reports

Antitumor activity and mode of action of 2-thio-6-azauridine (NSC-146268) on L1210 leukemia.

Published in Cancer chemotherapy reports

Pulmonary fibrosis following multiple treatment with bleomycin (NSC-125066) in dogs.

Published in Cancer chemotherapy reports

Clinical trial of weekly doses of vinblastine (NSC-49842) combined with vincristine (NSC-67574) in malignant lymphomas a...

Published in Cancer chemotherapy reports

Letter: An evaluation of procarbazine (NSC-77213) in the treatment of acute leukemia.

Published in Cancer chemotherapy reports

Further experience with hexamethylmelamine (NSC-13875) in the treatment of carcinoma of the cervix.

Published in Cancer chemotherapy reports

Vinblastine (NSC-49842) plus vincristine (NSC-67574) given in intensive 3-day courses as therapy for lymphomas, sarcomas...

Published in Cancer chemotherapy reports